What is the debt of Merck & Co this year?
Merck & Co has a debt level of 28,214 USD this year.
Merck & Co Debt 2024
Merck & Co Debt
28,214 USD
Merck & Co Dividend yield
2.26 %
Ticker
MRK
ISIN
US58933Y1055
WKN
A0YD8Q
In 2024, Merck & Co's total debt was 28,214 USD, a 56.77% change from the 17,997 USD total debt recorded in the previous year.
Merck & Co Aktienanalyse
What does Merck & Co do?
The company Merck & Co Inc has a long history. It was founded in 1891 by the German pharmacist Friedrich Jacob Merck and is now based in Kenilworth, New Jersey, USA. The company has evolved over time into a globally operating company in the pharmaceutical and chemical industry. Merck & Co Inc's business model is based on the development, production, and marketing of medicines and products for the healthcare industry. The company collaborates with other partners such as universities, other companies, and governments to achieve the best possible scientific progress. Research and development play a very important role in this. Merck is divided into three main areas: The Human Health division, which specializes in the development of prescription drugs and products to improve human health. The second division is Animal Health, which focuses on animal medicines and care products. The third division, Life Science (formerly MilliporeSigma), is dedicated to the development of products and services for biopharmaceutical research and production to facilitate the discovery and manufacturing of medicines. Merck & Co Inc. offers a wide range of products, ranging from prescription medicines to specialty chemicals. Some of the most well-known drugs include Januvia for the treatment of type 2 diabetes and Keytruda, an immuno-oncology drug used in the treatment of various types of cancer. Other well-known drugs from Merck & Co Inc. include Gardasil for the prevention of HPV infections, Propecia for the treatment of male pattern hair loss, and Zetia for the treatment of high cholesterol. The company is extremely innovative and has made significant advances in pharmaceutical research in recent decades. Merck & Co Inc. has won numerous awards over the years, including the "2018 Australian Financial Review Boss Most Innovative Companies Award" and the "2018 Global Energy Award for Technology Innovation". Merck & Co Inc. operates worldwide and has subsidiaries and partnerships in many countries. The company has about 69,000 employees and distributes its products in over 140 countries. Merck & Co Inc.'s products are typically prescription-only and prescribed by doctors and professionals. Overall, Merck & Co Inc. is a company with an impressive history that is now one of the leading companies in the pharmaceutical and chemical industry. Thanks to its innovation and its consistent focus on the needs of patients and healthcare professionals, it is able to successfully meet challenges in the healthcare industry and set new standards. Merck & Co ist eines der beliebtesten Unternehmen auf Eulerpool.com.Debt Details
Understanding Merck & Co's Debt Structure
Merck & Co's total debt refers to the cumulative financial obligations the company owes to external parties. This can include short-term and long-term borrowings, bonds, loans, and other financial instruments. Assessing the company's debt levels is crucial for evaluating its financial health, risk profile, and ability to fund operations and expansions.
Year-to-Year Comparison
Analyzing Merck & Co's debt structure over the years provides insights into the firm’s financial strategy and stability. A reduction in debt can indicate financial strength and operational efficiency, while an increase may signal growth investments or potential financial challenges ahead.
Impact on Investments
Investors pay close attention to Merck & Co’s debt levels as they can influence the company’s risk and return profiles. Excessive debt can lead to financial strain, while moderate and well-managed debt can be a catalyst for growth and expansion, making it a critical aspect of investment evaluations.
Interpreting Debt Fluctuations
Shifts in Merck & Co’s debt levels can be attributed to various operational and strategic factors. An increase in debt might be geared towards funding expansion projects or enhancing operational capacity, while a decrease may indicate profit realizations or an approach to minimize financial risk and leverage.
Frequently Asked Questions about Merck & Co Stock
What was the debt of Merck & Co compared to the previous year?
The debt of Merck & Co has increased by 56.77% compared to the previous year increased.
What are the consequences of high debt for investors in Merck & Co?
High debt can pose a risk for investors of Merck & Co, as it can weaken the company's financial position and hinder its ability to fulfill its obligations.
What are the consequences of low debt for investors of Merck & Co?
Low debt means that Merck & Co has a strong financial position and is able to fulfill its obligations without overburdening its finances.
How does an increase in debt from Merck & Co affect the company?
An increase in debt of Merck & Co can adversely affect the financial condition of the company and result in a higher burden on its finances.
How does a reduction of debt of Merck & Co affect the company?
A reduction in debt of Merck & Co can strengthen the company's financial position and improve its ability to meet its financial obligations.
What are some factors that influence the debt of Merck & Co?
Some factors that can influence the debt of Merck & Co include investments, acquisitions, operating costs, and revenue development.
Why are the debts of Merck & Co so important for investors?
The debts of Merck & Co are important for investors as they serve as an indicator of the company's financial stability. It provides investors with information on how the company fulfills its financial obligations.
What strategic measures can Merck & Co take to change the debt?
To change the debt, Merck & Co can take measures such as cost savings, increasing revenue, selling assets, making investments, or forming partnerships. It is important for the company to conduct a thorough review of its financial situation to determine the best strategic actions to change its debt.
How much dividend does Merck & Co pay?
Over the past 12 months, Merck & Co paid a dividend of 2.96 USD . This corresponds to a dividend yield of about 2.26 %. For the coming 12 months, Merck & Co is expected to pay a dividend of 3.37 USD.
What is the dividend yield of Merck & Co?
The current dividend yield of Merck & Co is 2.26 %.
When does Merck & Co pay dividends?
Merck & Co pays a quarterly dividend. This is distributed in the months of July, October, January, April.
How secure is the dividend of Merck & Co?
Merck & Co paid dividends every year for the past 26 years.
What is the dividend of Merck & Co?
For the upcoming 12 months, dividends amounting to 3.37 USD are expected. This corresponds to a dividend yield of 2.58 %.
In which sector is Merck & Co located?
Merck & Co is assigned to the 'Health' sector.
Wann musste ich die Aktien von Merck & Co kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of Merck & Co from 4/5/2024 amounting to 0.77 USD, you needed to have the stock in your portfolio before the ex-date on 3/14/2024.
When did Merck & Co pay the last dividend?
The last dividend was paid out on 4/5/2024.
What was the dividend of Merck & Co in the year 2023?
In the year 2023, Merck & Co distributed 2.8 USD as dividends.
In which currency does Merck & Co pay out the dividend?
The dividends of Merck & Co are distributed in USD.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
The Merck & Co stock can be added to a savings plan with the following providers: Trade Republic, Scalable Capital and Consorsbank
Andere Kennzahlen von Merck & Co
Our stock analysis for Merck & Co Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Merck & Co Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.
